首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 546 毫秒
1.
The HLA class II sequences included in this compilation are taken from publications listed in the accompanying paper, Nomenclature for factors of the HLA system, 1990 (Bodmer et al. 1991) and Nomenclature for factors of the HLA system, 1989 (Bodmer et al. 1990). Where discrepancies have arisen between reported sequences the original authors have been contacted where possible, and necessary amendments to published sequences have been incorporated into this alignment. Future sequencing may identify errors in this list and we would welcome any evidence that helps to maintain the accuracy of this compilation. In the sequence alignments identity between residues is indicated by a hyphen (-). Unavailable sequence is indicated by an asterisk (*). Gaps in the sequence are inserted to maintain the alignment between different alleles showing variation in amino acid number.  相似文献   

2.
The HLA class I sequences included in this compilation are taken from publications listed in the accompanying paper, Nomenclature for factors of the HLA system, 1990 (Bodmer et al. 1991) and Nomeclature for factors of the HLA system, 1989 (Bodmer et al. 1990). Where discrepancies have arisen between reported sequences the original authors have been contavted where possible, and necessary amendments to published sequences have been incorporated into this alignment. Future sequencing may identify errors in this list and we would welcome any evidence that helps to maintain the accuracy of this compilation. In the sequence alignments identify between residues is indicated by a hyphen (-). Unavailable sequence is indicated by a period (.). Gaps in the sequence are inserted to maintain the alignment between different alleles showing variation in amino acid number.  相似文献   

3.
The HLA class II sequences included in this compilation are taken from publications listed in the papers: Nomenclature for factors of the HLA system, 1989, Nomenclature for factors of the HLA system, 1990, and Nomenclature for factors of the HLA system, 1991 (WHO Nomenclature Committee 1990, 1991, 1992). Where discrepancies have arisen between reported sequences, the original authors have been contacted where possible, and necessary amendments to published sequences have been incorporated into this alignment. Future sequencing may identify errors in this list, and we would welcome any evidence that helps to maintain the accuracy of this compilation. In the sequence alignments, identity between residues is indicated by a hyphen (-), an unavailable sequence is indicated by an asterisk (*), and gaps in the sequence are inserted to maintain the alignment between different alleles showing variation in amino acid number. Correspondence to: S. G. E. Marsh.  相似文献   

4.
The nucleotide sequence data reported in this paper have been submitted to the EMBL nucleotide sequence database and have been assigned the accession number X96986. The nameDPB1 * 6601 was officially assigned by the WHO Nomenclature Committee in May 1996. This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al. 1995), names will be assigned to new sequences as they are identified. Lists of such sequences will be published in the following WHO Nomenclature Report  相似文献   

5.
The nucleotide sequence data reported in this paper have been submitted to the GenBank nucleotide sequence data base and have been assigned the accesion number M74842. The name DQB1*0304 has been officially assigned by the WHO Nomenclature Committee in November 1991. This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (WHO Nomenclature Committee for factors of the HLA system, 1991), names will be assigned to new sequences as they are identified. List of such new names will be published in the following WHO Nomenclature Report.  相似文献   

6.
The name B *4406 was officially assigned by the WHO Nomenclature Committee in February 1995. This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al. 1994), names will be assigned to new sequences as they are identified. Lists of such new names will be published in the following WHO Nomenclature Report. The nucleotide sequences reported in this Papers have been submitted to the EMBL nucleotide sequence database and have been assigned the accession numbers X83400 (HLA-B promoter region), X83401 (exon 1), X83402 (exon 2), and X83403 (exon 3)  相似文献   

7.
The nucleotide sequence data reported here have been submitted to the Genome Sequence Database and have been assigned the accession number L32810. The name DRB1 *0811 was officially assigned by the WHO Nomenclature Committee in March 1994. This follows the policy that, subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al. 1992), names will be assigned to new sequences as they are identified. Lists of such new names will be published in the following WHO Nomenclature Report  相似文献   

8.
The nucleotide sequence data reported in this paper have been submitted to the EMBL database and have been assigned the accession number X81363. The name B * 4102 was officially assigned by the WHO Nomenclature Committee in November 1994. This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al. 1994), names will be assigned to new sequence as they are identified. Lists of such new names will be published in the following WHO Nomenclature Report  相似文献   

9.
The nucleotide sequence data reported in this paper have been submitted to the GenBank nucleotide sequence database and have been assigned the accession number L34353. The name listed for this sequence has been officially assigned by the WHO Nomenclature Committee in August 1994. This follows the agreed policy that subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al 1994), names will be assigned to new sequences as they are identified. Lists of such new names will be published in the following WHO Nomenclature Report  相似文献   

10.
The nucleotide sequence data reported in this paper have been submitted to the EMBL/GenBank nucleotide sequence database and have been assigned the accession number Z48631. The name listed for this sequence was officially assigned by the WHO Nomenclature Committee in November 1994. This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al. 1994), names will be assigned to new sequences as they are identified. Lists of such new names will be published in the following WHO Nomenclature Report  相似文献   

11.
The present work collects the new names of syntaxa (in the sense of the Code of Phytosociological Nomenclature,Barkman et al. 1986) above subassociation, rank found in the literature received by the Library of the Conservatoire et Jardin botaniques in Geneva. For the year 1992, 658 names have been listed. For each one of them, an appreciation about its validity is given relating to the Code of Phytosociological Nomenclature. Fifteen names are given in addition to the Indexes 1987, 1990 and 1991 (Theurillat & Moravec 1990, 1993, 1994).  相似文献   

12.
This Index collects the new names of syntaxa (in the sense of the Code of Phytosociological Nomenclature,Barkman et al. 1986) above subassociation rank found in the literature received by the Library of the Conservatoire Botanique in Geneva. For the year 1991 591 names have been listed. Each one is accompanied by an appreciation about its validity with respect to the Code of Nomenclature. 25 names are given in addition to the Indexes 1988, 1989 and 1990 (Theurillat & Moravec 1991, 1992, 1993).  相似文献   

13.
 Prior studies in the Schmiedeleut Hutterites of South Dakota have demonstrated associations between human leukocyte antigen (HLA) haplotype matching and fetal loss (Ober et al. 1992) and mate preferences (Ober et al. 1997), as well as deficiencies of homozygotes for HLA haplotypes (Kostyu et al. 1993). These studies were based on the serologically-defined five-locus HLA-A, -C, -B, -DR, -DQ haplotype. To further elucidate the effects of specific major histocompatibility (MHC) loci or regions on fetal loss and mate choice, we genotyped a sample of Hutterites for 14 MHC loci by DNA or biochemical methods. Typing for additional loci in the HLA-A to HLA-DPB1 region increased the number of recognized Hutterite MHC haplotypes to 67, and further localized the site of cross-over in 9 of 15 recombinant haplotypes. Hutterite MHC haplotype sequences are similar to those observed in outbred Caucasians, suggesting that the influence of HLA haplotypes on fetal loss and mating structure may be general. Received: 1 May 1998 / Revised: 2 December 1998  相似文献   

14.
The major histocompatibility complex (MHC) class II region of ruminants appears to have a structure broadly similar to that of the human class II or HLA-D region. Restriction fragment length polymorphism (RFLP) studies of class II genes in cattle (Andersson et al. 1988; Anderson and Rask 1988; Sigurdardottir et al. 1988, 1991 b), and in sheep (Scott et al. 1987), have provided an estimate of the number and type of class II genes in these species. The subsequent cloning and sequencing of sheep and cattle class II genes (Muggli-Cockett and Stone 1989; Groenen et al. 1990; van der Poel et al. 1990; Andersson et al. 1991; Scott et al. 1991 a, b; Ballingall et al. 1992; Sigurdardottir et al. 1991 a, 1992), have demonstrated that they are highly homologous to their human counterparts. Of more interest, therefore, are loci within the ruminant MHC which differ from the HLA class II region.Three distinguishing features of the ruminant class II region described to date are, firstly, the apparent absence of a DP-like isotype, secondly, the variability in the number of DQ genes between haplotypes (Andersson and Rask 1988), and thirdly, the presence of class II genes presumed to be unique to the ruminant (Andersson et al. 1988). The presence of two such genes, designated DYA and DYB, was deduced from RFLP studies of cattle DNA. These genes were shown to segregate together with the DOB gene in one region separated by a recombination distance of 17 cM from the region which contains the DQA, DQB, DRB, DRA, and C4 loci (Andersson et al. 1988). Subsequently, Bota-DYA was cloned from a phage library and sequenced (van der Poel et al. 1990; Acc. Nos. m30119 and m30118). The sequence of part of a similar gene in the goat, obtained by PCR by using primers derived from the cattle sequence, has recently been reported (Mann et al. 1993; Acc. No. m94325). However, there has been no report of the cloning of a B gene partner for the DYA gene. A novel cattle class II B gene designated Bota-DIB was cloned from a phage library and sequenced by Stone and Muggli-Cockett (1990). This was shown to be a single copy gene of limited polymorphism, which on the basis of RFLP analysis was probably not Bota-DYB but did appear to be distinct from other known cattle class II genes. The species distribution of this B gene was shown to be restricted to Cervidae, Giraffidae, and Bovidae (Stone and Muggli-Cockett 1993). However, it is not known whether any of these novel genes are functional.Expressed human class II genes usually occur as A/B gene pairs situated close to each other on the chromosome. This is also the case with Bota-DQ genes (Groenen et al. 1990) and Ovar-DQ genes (Deverson et al. 1991; Wright and Ballingall 1994). We used the techniques of cosmid cloning and DNA-mediated gene transfection to determine whether there is a sheep equivalent of the Bota-DYA gene, whether there is a DYB gene partner, and whether there is a protein product.A cosmid library was constructed from DNA prepared from a Finnish Landrace ram. The library was screened with Ovar-DQA, Ovar-DQB, HLA-DQA, and HLA-DQB gene probes at low stringency. A cosmid clone, 365, was obtained which hybridized weakly to both the Ovar gene probes. Restriction maps of the clone were produced for the enzymes Eco R1, Bam HI, Hin dIII, Sac I and Sma I. When the maps were compared to those published for the phage clones containing the Bota-DYA (van der Poel et al. 1990) and the Bota-DIB gene (Stone and Muggli-Cockett 1990), there was an imperfect match (Figure 1 shows the Eco RI maps). However, the sequence data for the A and B genes in cosmid 365 are more convincing. The sequences of exons 2 and 3 of the A gene in cosmid 365 and the Bota-DYA gene, together with the partial sequence from the third exon of the Cahi-DYA gene are shown in Figure 2 A. The predicted amino acid translations of these genes together with those of other published sheep MHC class II A genes are shown in Figure 2 B. The A gene in cosmid 365 had all the salient features of an MHC class II A gene. It showed a high sequence similarity to the cattle and caprine DYA genes and much less so to the Ovar-DRA gene (Ballingall et al. 1992; Acc. No z11600) and the Ovar-DQA1 and DQA2 (Scott et al. 1991 a; Acc. Nos. m33304 and m33305), as detailed in Table 1. The cosmid A gene showed low sequence similarity to the sheep DNA (formerly DZA) gene (unpublished observations). The A gene described here is clearly the sheep homologue of the Bota-DYA gene.The sequences of the second, third, and fourth exons of the B gene in cosmid 365 are shown in Figure 3 A together with those of the Bota-DIB gene (Stone and Muggli-Cockett 1990). Unfortunately, the presence of a Bam HI site in exon 2 of the sheep gene caused a truncation at this point, during the cloning procedure and so a part of exon 2, the whole of exon 1, and all the upstream regulatory elements were missing. The predicted amino acid translations of exons 2, 3, and 4 are shown together with those of an Ovar-DQB (Scott et al. 1991 a; Acc. No. m33323) and an expressed Ovar-DRB gene (Ballingall et al. 1992; Acc. No. z11522) in Figure 3 B.  相似文献   

15.
Recent data suggest that HLA-B locus alleles can evolve quickly in native South American populations. To investigate further this phenomenon of new HLA-B variants among Amerindians, we studied samples from another South American tribe, the Cayapa from Ecuador. We selected individuals for HLA-B molecular typing based upon their HLA class II typing results. Three new variants of HLA-B39 and one new variant of HLA-B15 were found in the Cayapa: HLA-B *3905, HLA-B*3906, HLA-B*3907, and HLA-B *1522. A total of thirteen new HLA-B alleles have now been found in the four South American tribes studied. Each of these four tribes studied, including the Cayapa, had novel alleles that were not found in any of the other tribes, suggesting that many of these new HLA-B alleles may have evolved since the Paleo-Indians originally populated South America. Each of these 13 new alleles contained predicted amino acid replacements that were located in the peptide binding site. These amino acid replacements may affect the sequence motif of the bound peptides, suggesting that these new alleles have been maintained by selection. New allelic variants have been found for all common HLA-B locus antigenic groups present in South American tribes with the exception of B48. In spite of its high frequency in South American tribes, no evidence for variants of B48 has been found in all the Amerindians studied, suggesting that B48 may have unique characteristics among the B locus alleles.The nucleotide sequence data reported in this paper have been submitted to the GenBank nucleotide sequence database and have been assigned the accession numbers U14756 (HLA-B *1522), U15683 (HLA-B *3905), U15639 (HLA-B *3906), and U15640 (HLA-B *3907)The names listed for these sequences were officially assigned by the WHO nomenclature Committee in September 1994, B *3905, and November 1994, B *1522, B*3906, and B *3907. This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al. 1994), names will be assigned to the new sequences as they are identified. Lists of such new names will be published in the following WHO Nomenclature Report.  相似文献   

16.
The identification of 19 different HLA-DPB1 sequences implicates the existence of more DP specificities than can be typed for with cellular methods. How many of the DP sequences can be specifically recognized by T cells, and which of the polymorphic regions can contribute to the specificity of allorecognition, is not known. In order to investigate the distribution and the immunological relevance of recently described DPB1 alleles, we have typed a panel of 98 randomly selected Dutch Caucasoid donors for the HLA-DPB1 locus by oligonucleotide typing. Comparison of the typing results with primed lymphocyte typing (PLT) defined DP specificities shows an extremely good correlation. Moreover, additional alleles could be defined by oligonucleotide typing reducing the number of DP blanks in the panel. By selecting the appropriate responder stimulator combinations we were able to show that distinctive PLT reagents against oligonucleotide defined specificities DPB1*0401, DPB1*0402, DPB1*0901, and DPB1*1301 can be generated. To investigate in more detail which part of the DP molecule is responsible for the specificity of T-cell recognition, T-cell clones were generated against HLA-DPw3. The clones were tested for the recognition of stimulators carrying DPB1 alleles which had been defined by oligonucleotide typing and sequence analyses and which differed in a variable degree from DPB1*0301. The recognition patterns demonstrated that differences of one amino acid in polymorphic regions situated either in the beta sheets or alpha helix of the hypothetical model of the HLA class II molecule can eliminate T-cell recognition. Furthermore, sequence analyses revealed a new DPB1 allele designated DPB1*Oos.The nucleotide sequence data reported in this paper have been submitted to the GenBank nucleotide sequence database and have been assigned the accession number M58608. The name DPB1*2001 has officially been assigned to the DPB*Oos allele by the WHO nomenclature Committee in March 1991. This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Bodmer et al. 1990b), names will be assigned as they are identified. Lists of such new names will be published in the following WHO nomenclature report.  相似文献   

17.
Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) cause cystic fibrosis (CF) (Collins, 1992). Over 500 naturally occurring mutations have been identified in CF gene which are located in all of the domains of the protein (Kerem et al., 1990; Mercier et al., 1993; Ghanem et al., 1994; Fanen et al., 1992; Ferec et al., 1992; Cutting et al., 1990). Early studies by several investigators characterized CFTR as a chloride channel (Anderson et al.; 1991b,c; Bear et al., 1991). The complex secondary structure of the protein suggested that CFTR might possess other functions in addition to being a chloride channel. Studies have established that the CFTR functions not only as a chloride channel but is indeed a regulator of sodium channels (Stutts et al., 1995), outwardly rectifying chloride channels (ORCC) (Gray et al., 1989; Garber et al., 1992; Egan et al., 1992; Hwang et al., 1989; Schwiebert et al., 1995) and also the transport of ATP (Schwiebert et al., 1995; Reisin et al., 1994). This mini-review deals with the studies which elucidate the functions of the various domains of CFTR, namely the transmembrane domains, TMD1 and TMD2, the two cytoplasmic nucleotide binding domains, NBD1 and NBD2, and the regulatory, R, domain.  相似文献   

18.
The CRIPTO gene encodes a novel human growth factor structurally related to epidermal growth factor. We localized the CRIPTO gene to chromosome 3p21 by fluorescence in situ hybridization with a cosmid clone containing 40 kb of the CRIPTO genomic region (TDGF-1). To suppress hybridization to CRIPTO-related sequences, present in multiple copies in the human genome, hybridization was carried out in the presence of unlabeled CRIPTO cDNA in excess over the probe. Our finding confirms the provisional mapping of the CRIPTO gene to chromosome 3, and assigns it precisely to a chromosomal region involved in several rearrangements occurring in malignancy.CRIPTO-specific sequences are present in multiple copies in the human genome (Dono et al. 1991). Two genomic CRIPTO-encoding sequences, TDGF-1 and TDGF-3, have been isolated and characterized. TDGF-1 corresponds to the structural gene encoding the protein expressed in teratocarcinoma cells (Ciccodicola et al. 1989). TDGF-3, possibly a functional pseudogene, corresponds to a complete copy of the TDGF-1 mRNA that contains seven base changes representing both silent and replacement substitutions in the coding region (Dono et al. 1991). By somatic cell hybrid analysis TDGF-1 has been assigned to chromosome 3, and TDGF-3 to the Xq21–22 region (Dono et al. 1991).  相似文献   

19.
The present work collects the new names of syntaxa (in the sense of the Code of Phytosociological Nomenclature,Barkman et al. 1986) above subassociation rank found in the literature received by the Library of the Conservatoire Botanique in Geneva. For the year 1989, 588 names have been listed. For each one of them, an appreciation about its validity is given relating to the Code of Nomenclature. 15 names are given in addition to the “Index 1987” (Theurillat etMoravec 1990) and 53 to the “Index 1988” (Theurillat etMoravec 1991).  相似文献   

20.
The present work collects the new names of syntaxa (in the sense of the Code of Phytosociological Nomenclature,Barkman et al. 1986) above subassociation rank found in the literature received by the Library of the Conservatoire Botanique in Geneva. For the year 1990 454 names have been listed. For each one of them, a first appreciation about its validity is given relating to the Code of Nomenclature. 8 names are given in addition to the Index 1987 (Theurillat andMoravec 1990), 9 to the Index 1988 (Theurillat andMoravec 1991) and 4 to Index 1989 (Theurillat andMoravec 1992).  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号